SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Trends Analyst Outlook Journalist POV

10 hedge funds and large institutions have $637K invested in Salarius Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$9.33K

Top Sellers

1
-$155K
2
-$59.5K
3
-$8K
4
Deutsche Bank
Deutsche Bank
Germany
-$8K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$341K
2
$104K
3
$59K
4
$52K
5
$24K
6
$17K
7
$15K
8
$14K
9
$4K
10
$2K
11
$2K
12
$2K
13
$1K
14
–
15
–
16
–
17
–